Loading clinical trials...

Capnometry-Assisted Breathing Training for COPD | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Capnometry-Assisted Breathing Training for COPD

NCT03457103•NYU Langone Health

Summary

Capnometry-Assisted Breathing Training for COPD (CATCH) is a behavioral intervention that aims to promote optimal, self-regulated, mindful breathing. A portable capnometer is used in-session to provide continuous visual feedback of Respiratory Rate (RR), End-Tidal Carbon Dioxide Tension (ETCO2), and breathing pattern. The tailored CATCH intervention will emphasize a slow, quiet, regular, nasal breathing pattern, as well as pursed lips breathing (PLB). CATCH is once weekly for 6 weeks, for a total of 6 sessions; each session is approximately 60 minutes long. The principal investigator will implement the CATCH intervention. The principal investigator will implement the CATCH intervention. Patients will use the Address Stress app on a smart phone or computer tablet as part of their home breathing exercises.

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•over 40 years of age
•has COPD documented in their electronic medical record, as defined by FEV1/FVC of \< 0.70 on pulmonary function testing (spirometry), or as shown on a chest CT
•Can maintain oxygen saturation (SaO2) ≥ 90% on room air at rest
•Is medically cleared to participate in NYULMC's outpatient pulmonary rehabilitation program
•English speaking. Pregnant patients will not be enrolled in the study

Exclusion Criteria

•Requires 24-hour supplemental oxygen
•Has cognitive impairment as measured by ≤23/30 on the Mini Mental State Examination (MMSE)
•Is actively being treated for lung cancer (E.g. with chemotherapy or upcoming surgery)
•Has morbid obesity (BMI \> 40)
•Is currently smoking
•Has unstable cardiac disease defined by a history of a myocardial infarction in the past 3 months

Locations (1)

New York University School of Medicine

New York, New York, United States

Key Dates

Start Date

June 16, 2015

Primary Completion Date

August 2, 2019

Completion Date

August 2, 2019

Last Updated

August 18, 2021

Enrollment

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Capnometry-Assisted Training for COPD to Slow the Breath (CATCH)

DEVICE

Pulmonary Rehabilitation (PR)

DEVICE

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGPHASE3

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

Chronic Obstructive Pulmonary Disease

View study

RECRUITINGNA

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Capnometry-Assisted Breathing Training for COPD

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Probiotics in Pulmonaty Rehabilitation for COPD

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease